Cargando…
Data-driven analysis and druggability assessment methods to accelerate the identification of novel cancer targets
Over the past few decades, drug discovery has greatly improved the outcomes for patients, but several challenges continue to hinder the rapid development of novel drugs. Addressing unmet clinical needs requires the pursuit of drug targets that have a higher likelihood to lead to the development of s...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732000/ https://www.ncbi.nlm.nih.gov/pubmed/36514341 http://dx.doi.org/10.1016/j.csbj.2022.11.042 |